AI Article Synopsis

  • Familial hemophagocytic lymphohistiocytosis (FHL) is a rare disorder that affects the immune system, leading to uncontrolled activation of macrophages and impaired cytotoxic cells.
  • The study describes four patients with FHL type 2 from Latin America, with one diagnosed at 2 months old and the others diagnosed later in childhood, revealing two known genetic mutations (L17fsx50 and R54C).
  • A prevalent genetic haplotype (R54C/A91V) was found in most patients, indicating it may lead to later onset of the disease, underlining the importance of genetic testing for accurate diagnosis of FHL.

Article Abstract

Familial hemophagocytic lymphohistiocytosis (FHL), is a rare autosomal recessive disorder characterized by an impairment of cytotoxic cells and uncontrolled activation of macrophages. This study presents the first description of four patients with FHL type 2 in Latin America. Patient 1 fulfilled the disease diagnostic criteria since 2 months of age, whereas patients 2, 3 and 4 exhibited the typical manifestations of the disease only later in their childhood. The PRF1 genetic analysis in these patients revealed two previously reported mutations: L17fsx50 and R54C. Interestingly, seven out of the 8 alleles evaluated here in patients carried the haplotype R54C/A91V, suggesting that this is a highly frequent FHL type 2 allele in Colombia. This haplotype confers residual cytotoxic function leading to late onset disease. Therefore, this report highlights the remarkable complexity of FHL diagnostic, emphasizing the importance of the genetic characterization of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10875-012-9680-5DOI Listing

Publication Analysis

Top Keywords

haplotype r54c/a91v
8
late onset
8
onset disease
8
fhl type
8
disease
5
analyses prf1
4
prf1 gene
4
gene individuals
4
individuals hemophagocytic
4
hemophagocytic lymphohystiocytosis
4

Similar Publications

Article Synopsis
  • Familial hemophagocytic lymphohistiocytosis (FHL) is a rare disorder that affects the immune system, leading to uncontrolled activation of macrophages and impaired cytotoxic cells.
  • The study describes four patients with FHL type 2 from Latin America, with one diagnosed at 2 months old and the others diagnosed later in childhood, revealing two known genetic mutations (L17fsx50 and R54C).
  • A prevalent genetic haplotype (R54C/A91V) was found in most patients, indicating it may lead to later onset of the disease, underlining the importance of genetic testing for accurate diagnosis of FHL.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!